Research Interests
Dr Grieve is open to wide-ranging PhD applications from candidates with a basic science or clinical background.
His fields of interest include;
- cardiovascular biology
- pathophysiology
- pharmacology
Previous research experience is desirable although not essential.
Public outreach & key achievements
- British Heart Foundation Northern Ireland - Investing in the future
- UK Houses of Parliament British Heart Foundation Research Reception
- QUB scientists' 'breakthrough' on cancer enzyme role
- British Society for Cardiovascular Research - Honorary Secretary
- British Heart Foundation Project Grants Committee
- NC3Rs Grant Assessment Panel
Research students
PhD Title | Does NOX4 play a key role in direct reprogramming of fibroblasts into endothelial cells and underlie their ability to promote angiogenesis? |
Country | Afghanistan |
Years of Study | 2015-2018 |
PhD Title | Selective targeting of glucagon-like peptide-1 signalling as a novel approach to prevent adverse cardiac remodelling associated with diabetes |
Country | Jordan |
Years of Study | 2016-2019 |
Phd Title | Does endothelial Nox4 NADPH oxidase play a key role in the development and progression of diabetic cardiac remodelling? |
Country | England |
Yeras of Study | 2016-2019 |
Alumni: Where are they now
PhD Title | Investigation of the effects of the glucagon-like peptide-1 mimetic exendin-4 on cardiac remodelling in diabetes |
Country | England |
Years of Study | 2011-2015 |
Current position | Postdoctoral Research Associate, Baker Heart and Diabetes Institute, Melbourne, Australia |
PhD Title | Mechanisms underlying the interaction between PPARα and NADPH oxidases in the hypertrophic cardiomyocyte |
Country | Northern Ireland |
Years of Study | 2009-2013 |
Current position | Postdoctoral Research Associate, University of Glasgow, UK |
Phd Title | Investigation into the mechanism of Nox2 NADPH oxidase-dependent signalling in doxorubicin cardiotoxicity |
Country | England |
Years of Study | 2016-2019 |
Current position | Teaching Fellow, Queen’s University Belfast, UK |